Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis
Objective: This study aimed to assess neoplasm risk in patients with rheumatoid arthritis (RA) treated with fostamatinib.Methods: Studies were collected from electronic databases of OVID Medline, OVID EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science. We included studies tha...
Saved in:
Main Authors: | Yuehong Chen (Author), Huan Liu (Author), Yunru Tian (Author), Zhongling Luo (Author), Geng Yin (Author), Qibing Xie (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Yuehong Chen, et al.
Published: (2021) -
Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Yaqi Kang, et al.
Published: (2019) -
Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta‐analysis
by: Rafaela C.E. Santo, et al.
Published: (2018) -
Effectiveness and Safety of Iguratimod Monotherapy or Combined With Methotrexate in Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
by: Dan Ouyang, et al.
Published: (2022) -
Association between maternal rheumatoid arthritis and small for gestational age neonates: a systematic review and meta-analysis
by: Lv Tian, et al.
Published: (2023)